Skip to content
Sunday, October 11, 2026
Openly Digest provides in-depth analysis of current events,…

Patients Coming Off Slimming Jabs Regain Pounds at a Quadrupled Rate Compared to Dieters

Image of medical syringe and weighing machine
Weight management involves ongoing approaches.

Fresh analysis reveals that individuals who stop using popular weight-loss injections like Wegovy and Mounjaro tend to recover shed pounds at a significantly accelerated pace than those who end traditional diet and exercise plans.

Research printed in a leading medical journal points out that while overweight people frequently drop substantial amounts of their body weight while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month upon discontinuation.

"Individuals buying such medications must be informed of the potential of rapid weight regain when the medication concludes," cautioned expert Dr. Susan Jebb.

Such speed of regain means a return to pre-treatment mass in about 18 months.

Comparing Treatments

The study, which reviewed dozens of studies involving thousands of participants, compared the results of these new drugs with older methods.

Scientists point out that people who shed pounds through lifestyle changes alone generally see a less rapid creep back—perhaps 0.1 kg a month—once they finish.

Explaining the Quick Regain

Doctors propose the way of the injections is key to understanding the heightened rebound.

GLP-1 drugs imitate a body's own chemical called GLP-1, which helps regulate appetite.

"Long-term administration of the hormone concentrations far above than the body's typical production might result in the system to generate a reduced amount of its own natural GLP-1, and may also diminish responsiveness to its effects," said Dr. Adam Collins, a dietetics expert.

"Discontinuation of this GLP-1 'fix' results in hunger is no longer kept in check, making overeating a significant risk."

A Chronic Issue?

The NHS suggest the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.

A number of clinicians say that, due to the significant potential of relapse, the treatment should be considered ongoing.

This view is echoed by pharmaceutical companies, who state that the results "highlight the long-term nature of obesity," similar to managing diseases like high blood pressure.

Patient Testimonies

Individuals who have discontinued the medication describe a intense resurgence of cravings.

"It was like a switch flipping and you become starving," described a patient.

This challenge is exacerbated if patients have not established lasting lifestyle or habit changes during treatment.

Significant Use

Recent estimates indicate that a significant number of adults in the UK have tried these injections in the last 12 months, with desire remaining high.

  • Use is higher among females compared to men.
  • The 40s and 50s demographic shows the greatest usage rates.
  • Many obtain the drugs through private healthcare rather than the NHS.

In conclusion, clinicians emphasize that while the jabs are effective tools for weight loss, they are not a standalone cure and lasting health benefits relies on integrated lifestyle management.

Written by

Jill Gomez

Lena Voss is a journalist and political analyst with over a decade of experience covering global affairs and social justice movements.

Openly Digest

Type to search articles.